Login to Your Account



Radius Health Raises $91M for Osteoporosis Phase III Trial

By Tom Wall


Wednesday, May 25, 2011
Radius Health Inc. raised $91 million – $66 million in equity financing and a $25 million term loan facility – primarily for a Phase III trial of lead candidate BA058 for the treatment of osteoporosis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription